Listing & Compliance Notices

AMERICAN REBEL HOLDINGS INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

“May 9, 2023, the Registrant received correspondence from Nasdaq noting that the Registrant was no longer in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605 (the “Notice”). The Notice also stated, among other things, that, pursuant to Nasdaq Listing Rule 5605(c)(4), the Registrant is entitled to a cure period in order to regain compliance with Nasdaq Listing Rule 5605(c)(2)(A), which cure period will expire upon (i) the earlier of either the date of the Registrant ‘s next annual shareholders’ meeting or April 4, 2024, or (ii) if the nex”

BAIYU Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“May 15, 2023, TD Holdings, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its common shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s common stock on Nasdaq. Under the Nasdaq Listing Rules, the Company has until Novem”

Nexalin Technology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“May 10, 2023, Nexalin Technology, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market, pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Market. Pursuant to Nasdaq Listing R”

Silvergate Capital Corp received a nyse delisting notice notice regarding late filing (rules 802.01E).

“May 11, 2023, the NYSE suspended trading in the Company’s securities and indicated to the Company that it expects to commence the delisting of the Company’s securities after the Company informed the NYSE that it will not file the 2022 10-K or any subsequent periodic reports as required by Sections 13(a) or 15(d) under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”). Later on May 11, 2023, the Company was notified by the NYSE that it had determined to commence proceedings to delist the Company’s securities from the NYSE pursuant to Section 802.01E of the NYSE Listed Co”

ARROW FINANCIAL CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“May 12, 2023, the Company received an additional notice from Nasdaq that the Company remains noncompliant with the Rule as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the “First Quarter Form 10-Q”) with the SEC by the required due date (the “May Nasdaq Notice” and, together with the April Nasdaq Notice, the “Nasdaq Notices”). As disclosed by the Company on its Notification of Late Filing on Form 12b-25, filed with the SEC on May 11, 2023, the Company was unable to timely file the First Quarter Form 10-Q without unreasonable effort or e”

Tempo Automation Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“May 10, 2023, Tempo Automation Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days prior to the date of the Letter, the Company’s market value of publicly held shares (“MVPHS”) was below the $15 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on”

Vislink Technologies, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“May 15, 2023, the Company received a letter from the Nasdaq notifying the Company that it had regained compliance with the Bid Price Rule, and as a result, the Common Stock continues to trade on the Nasdaq Capital Market. If in the future, the Company fails to satisfy the continued listing requirements of Nasdaq, such as its corporate governance requirements or the Bid Price Rule, Nasdaq may take steps to delist the Common Stock. Cautionary Statement Regarding Forward-Looking Statements Certain statements in this Current Report on Form 8-K are forward-looking within the meaning of the Private”

New Mountain Finance Corp received a nasdaq deficiency notice notice regarding audit committee.

“May 12, 2023, New Mountain Finance Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the previously disclosed resignation of Alice W. Handy from the Company’s Board of Directors (the “Board”) (as described in”

BIOCEPT INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

“May 15, 2023 to formally notify the Company of non-compliance with the Rule. The Company discussed the noncompliance with the Rule with Nasdaq on May 12, 2023. Pursuant to the Notice and Nasdaq rules, the Company will have 45 calendar days after receipt of the Notice to submit a plan to regain compliance with the Rule. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the date of the Notice for the Company to provide evidence of compliance. There can be no assurance that the Company will be able to regain compliance with the Rule.”

MITEK SYSTEMS INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“May 12, 2023, Mitek Systems, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Q2 Form 10-Q”) in a timely manner and because the Company remains delinquent in filing its Form 10-K for the year ended September 30, 2022 (the “Form 10-K”) and its Form”

Spectral AI, Inc. received a nasdaq extension granted notice regarding shareholders (rules 5550(a)(4)).

“May 8, 2023, Rosecliff Acquisition Corp I (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) advising that the Company had been granted a previously requested 180-day extension to July 21, 2023, to regain compliance with Rule 5550(a)(4), which requires the Company to hold a minimum of 500,000 publicly held shares. The Listing Qualifications Department of Nasdaq based its determination of an extension on the Company entering into the Business Combination Agreement with Spectral MD Holdings, Ltd. On or before July 21, 2023, the Company must file with the U.S. Securities an”

Airspan Networks Holdings Inc. received a nyse_american delisting notice notice regarding other.

“May 11, 2023, NYSE American LLC (the “NYSE American”) provided a written notice to Airspan Networks Holdings Inc. (the “Company” or “Airspan”) and publicly announced that NYSE Regulation has suspended trading in the Company’s warrants, each exercisable for one share of the Company’s common stock, ticker symbol MIMO WS (the “Warrants”) and determined to commence proceedings to delist the Warrants. To effect the delisting, the NYSE American will apply to the Securities and Exchange Commission (the “SEC”) to delist the Warrants pending completion of applicable procedures. The Company does not int”

MARKETWISE, INC. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).

“May 9, 2023, MarketWise, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications department (“Nasdaq”). The Notice indicated that, due to the resignation of Mr. Manuel Borges from the audit committee (the “Audit Committee”) of the board of directors (the “Board”) of the Company (in connection with his resignation from the Board), the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Listing Rule 5605. Listing Rule 5605 requires, among other things, that the Audit Committee be comprised of a minimum of three independent di”

Hyzon Motors Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 8, 2023, Hyzon Motors Inc. (the “Company”) received a letter (the “Notice”) from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”) for continued listing. The Bid Price Rule requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”) provides that a failure to meet the minimum bid price requirement exists if the”

Sports Entertainment Gaming Global Corp received a nasdaq delisting notice notice regarding late filing.

“May 15, 2023, the Company shall provide the Panel with updated financial projections for 2022 and 2023, including income statements and balance sheets; and 2. On or before May 15, 2023, the Company shall file with the SEC the amended Annual Report on Form 10-K for the year ended December 31, 2021 (the “Amended 2021 10-K”) and Quarterly Report on Form 10-Q for the quarter ending March 31, 2022. In accordance with the Panel’s decision, the Company filed its Amended 2021 10-K on May 10, 2023. The Company intends to comply with the remaining conditions set forth by the Panel, as stated in the”

Knightscope, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“May 11, 2023, Knightscope, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s Class A Common Stock has been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s Class A Common Stock on The Nasdaq Global Market. The Company has 180 calendar days, or until November 7, 2023, to regain compliance wi”

Jaguar Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 10, 2023, Jaguar Health, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180 calendar day grace period, or until November 6, 2023, to regain compliance with the minimum bid price requirement. The continued listing standard”

Zeo Energy Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(A)).

“May 10, 2023, ESGEN Acquisition Corporation (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Market Value Standard”). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 545”

TuSimple Holdings Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“May 5, 2023, TuSimple Holdings Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company not having timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Form 10-Q”) and its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) and Nasdaq has determined to deny the Company’s request for continued listing on Nasdaq. The Notice indicated that unless t”

Cyxtera Technologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(2), 5810(c)(3)(A)).

“ompany has failed to maintain a minimum bid price of at least $1.00 per share for the prior 30 consecutive trading day period from March 22, 2023 to May 4, 2023, based upon the closing bid price for its Class A common stock, as required by Nasdaq Listing Rule 5450(a)(2) (the “Bid Price Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s Class A common stock on the Nasdaq Global Select Market, and the Company’s Class A common stock will continue to trade under the symbol “CYXT.” In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until November 1, 2023 (the “Compliance Date”), to regain compliance with the Bid Price Requirement.”

EXICURE, INC. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605, 5605(c)(4)).

“May 10, 2023, Exicure, Inc. (the “ Company ”) received notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company is no longer in compliance with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rule 5605 as a result of the previously disclosed resignation of Hyukku Lee, effective May 3, 2023 . Nasdaq Rule 5605 requires the audit committee of the board of directors to be comprised of at least three independent directors (the “ Listing Requirement for Audit Committee ”). Pursuant to Nasdaq Listing Rule 5605(c)(4), the Company is entitled to a cure period to regain”

Aptinyx Inc. received a nasdaq delisting notice notice regarding other (rules 5101).

“May 10, 2023, Aptinyx Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Staff’s determination that the Company is a “public shell” as that term is defined in Nasdaq Listing Rule 5101, and the Company’s non-compliance with certain board and committee composition listing requirements, the Company would be delisted at the opening of business on May 19, 2023 unless the Company timely requests a hearing before a Nasdaq Hearings Panel to address the deficiencies and present a plan to regain complian”

ASP Isotopes Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).

“May 5, 2023, ASP Isotopes Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5810(c)(3)(A) (the “Minimum Bid Price Requirement”). The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or trading of the Company’s common s”

FAT PROJECTS ACQUISITION CORP received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(B)).

“ers and holders of record) of the Company’s common stock was less than 400 based on a shareholder analysis provided by the Company at Nasdaq’s request to Nasdaq on May 4, 3023, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5450(a)(2) that requires the Company to maintain 400 Total Holders of its common stock. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Global Market. The Notice states that the”

FAT PROJECTS ACQUISITION CORP received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“ers and holders of record) of the Company’s common stock was less than 400 based on a shareholder analysis provided by the Company at Nasdaq’s request to Nasdaq on May 4, 3023, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5450(a)(2) that requires the Company to maintain 400 Total Holders of its common stock. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Global Market. The Notice states that the”

Spectaire Holdings Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C)).

“May 5, 2023, Perception Capital Corp. II (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that, for the previous 30 consecutive business days, the Market Value of Publicly Held Shares (“ MVPHS ”) for the Class A ordinary shares of the Company, par value $0.0001 per share (“ Class A Ordinary Shares ”), was below the $15 million minimum MVPHS requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(3)(C) (the “ MVPHS Rule ”). The Letter is only a notification of defic”

ELUTIA INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“May 4, 2023, the Company received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Market Value Standard”). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rules 5550(b)(1) (Equity Standard) and 5550(b)(3) (Net In”

RiskOn International, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“May 8, 2023, BitNile Metaverse, Inc., a Nevada corporation (the “Company”) received a letter from the Listing Qualifications staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined to delist the Company’s common stock, par value $0.001 per share (the “Common Stock”) from The Nasdaq Capital Market, effective May 17, 2023, pursuant to Listing Rule 5810(c)(3)(A)(iii), as the Company’s common stock traded below $0.10 per share for 10 consecutive trading days. According to the letter, the Company has until May 15, 2023 to appeal the Staff’s”

SharpLink Gaming Ltd. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“May 10, 2023, Nasdaq notified the Company that since the bid price of the Company’s ordinary shares closed above $1.00 for ten consecutive trading days from April 26, 2023 through May 9, 2023, the Company had cured the bid price deficiency, its ordinary shares would not be suspended or delisted and the matter was considered closed. As a result, the Company is currently in compliance with the Rule and the Company’s ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol “SBET.” 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Reg”

Legacy IMBDS, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“May 3, 2023, the Company received a notification letter (the “Nasdaq Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that, because the Company has not yet filed the Form 10-K, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC. The Nasdaq Notice has no immediate effect on the listing or trading of the Company’s securities. Nasdaq has informed the Company that, under Nasdaq rules, the Company has until July 3”

Kaspien Holdings Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“May 4, 2023, the Company received written notice from Nasdaq that given the reported stockholders’ equity on the Company’s Form 10-K for the year ended January 28, 2023, the Company also is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). In accordance with the Nasdaq Listing Rules, the Company has been provided a period of 45 calendar days, or until June 20, 2023, to submit a plan to Nasdaq to regain compliance with the minimum stockholders’ equity requirement. If the Company’s plan i”

Kaspien Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 15, 2022, Kaspien Holdings Inc. (the “Company”) had received written notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), and must regain compliance with that requirement by June 12, 2023. Separately, on May 4, 2023, the Company received written notice from Nasdaq that given the reported stockholders’ equity on the Company’s Form 10-K for the year ended January 28, 2023, the Company also is not in compliance with the minimum”

Tevogen Bio Holdings Inc. received a nasdaq compliance regained notice regarding other (rules 5250(f)).

“May 5, 2023, the Company received notification from Nasdaq that the fee delinquency was cured and the Company is now in compliance with Nasdaq’s continued listing standards. The Company’ securities will continue to trade on The Nasdaq Stock Market, and Nasdaq considers the matter closed.”

Cascadia Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“May 3, 2023, Cascadia Acquisition Corp., a Delaware corporation (the “ Company ”), received a letter (the “ Letter ”) from the staff at The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the 30 consecutive trading days prior to the date of the Letter, the Company’s Minimum Value of Listed Securities (“ MVLS ”) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or tra”

iPower Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(3)).

“November 9, 2022, iPower Inc., a Nevada corporation (the “Company”), received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company’s common stock was trading below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “Bid Price Requirement”). The notification received from Nasdaq had no immediate effect on the Company’s Nasdaq listing”

EXICURE, INC. received a nasdaq deficiency notice notice regarding other.

“May 5, 2023, the Company notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of Hyukku Lee from the Company’s board of directors (the “ Board ”) (as described below in”

Akebia Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“May 9, 2023, Akebia Therapeutics, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of May 8, 2023, the Company’s securities were subject to delisting unless the Company timely appeals the Staff’s determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any”

Bridgeline Digital, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 3, 2023, Bridgeline Digital, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock (“Common Stock”) for the thirty (30) consecutive business days ended May 2, 2023, the Company no longer satisfies the requirement to maintain a minimum bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period o”

CYANOTECH CORP received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“May 2, 2023, Cyanotech Corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5550(a)(2) (“Bid Price Rule”). The Notice provided that, in accordance with the Nasdaq Listing Rule 5810(c)(3)(A) (the Compliance Period Rule), the Company has an initia”

Enservco Corp received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“from continuing operations and/or net losses in two of its three most recent fiscal years. As reported in its Form 10-K, the Company’s stockholders’ equity was approximately $1.2 million. The Company remains noncompliant with Section 1003(a)(ii) and Section 1003(a)(iii) of the Company Guide as reported on Company’s Form 8-K filed December 15, 2022 and Form 10-K.”

DIEBOLD NIXDORF, Inc received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“May 5, 2023, Diebold Nixdorf, Incorporated (the “Company”) received notice (the “Listing Standard Notice”) from the New York Stock Exchange (the “NYSE”) that as of May 4, 2023 it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common shares (the “Common Shares”) was less than $1.00 per share over a consecutive 30 trading-day period. The Listing Standard Notice has no immediate impact on the listing of the Common Shares on the NYSE, subject to the Com”

Schultze Special Purpose Acquisition Corp. II received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“May 2, 2023, Schultze Special Purpose Acquisition Corp. II (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(2) (the “Minimum Total Holders Rule”), which requires the Company to have at least 400 total holders for continued listing on the Nasdaq Global Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Na”

Inspirato Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“May 3, 2023, the Company received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5450(a)(1), because the minimum bid price of the Company’s Class A common stock has been below $1.00 per share for 30 consecutive business days (the “Notice”). The Notice has no immediate effect on the listing or trading of the Company’s Class A common stock or warrants on The Nasdaq Global Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until October 30, 2023, to regain compliance with the minimu”

Tempo Automation Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“May 5, 2023, Tempo Automation Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days prior to the date of the Letter, the closing bid price for the Company’s common stock, par value $0.0001 per share (“Common Stock”), was below the $1.00 per share requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). The Letter is only a notification of deficiency, not of im”

Leafly Holdings, Inc. /DE received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“May 2, 2023, the Company received a letter from Nasdaq notifying it that the Company's Common Stock would be subject to delisting from Nasdaq unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the "Panel"). The Panel has the discretion to grant the Company up to an additional 180 calendar days from May 2, 2023, to regain compliance with the Bid Price Rule. On May 8, 2023, the Company timely requested a hearing before the Panel at which it will present its detailed action plan to comply with the Bid Price Rule by effecting a reverse stock split, if necessary, and reque”

NantHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(A)).

“May 2, 2023, the Company received written notice (the “Notice”) from Nasdaq stating that the Company has not complied with the Public Float Requirement prior to the expiration of the Compliance Period. The Notice indicated that Company’s common stock would be suspended from trading on Nasdaq on May 11, 2023. The Company may appeal the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, by requesting a hearing before the Panel by 4:00 p.m. Eastern Time on May 9, 2023. The Company intends to timely request a hearin”

Comera Life Sciences Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“May 2, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Listing Rule 5550(a)(2). In accordance with Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until October 30, 2023, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.0”

micromobility.com Inc. received a nasdaq deficiency notice notice regarding market value.

“May 2, 2023, we received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating we were not in compliance with their continued listing requirement that we maintain a market value for our shares of Class A Common Stock together with our publicly traded warrants in excess of $35 million. We have 180 days from receipt of such notice (until October 30, 2023) to remedy such non-compliance, unless such period is extended at Nasdaq’s discretion. To regain compliance, our Class A Common Stock together with our publicly traded warrants must be valued at ove”

Oncorus, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“May 2, 2023, Oncorus, Inc. (the “ Company ”) received a notice (the “ Extension Notice ”) from the Listing Qualifications Department of the Nasdaq Stock Market (“ Nasdaq ”) informing the Company that Nasdaq granted the Company an additional 180 calendar days, or until October 30, 2023, to regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “ Rule ”). In connection with the Extension Notice, the listing of the Company’s common stock was transferred from the Nasdaq Global Market to the Nasda”

Moleculin Biotech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“May 5, 2023, Moleculin Biotech, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The deficiency letter does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. In ac”